Barnes Alane P

CIK 00015843481 companyDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001584348

Recent Transactions

50 trades

Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2026-05-13−62,500→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2026-05-13$5.04/sh+62,500→ 463,203 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2026-05-13$9.54/sh−62,500→ 400,703 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2026-03-16−150,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2026-03-16$5.51/sh+150,000→ 550,703 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2026-03-16$9.15/sh−150,000→ 400,703 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2025-12-17+255,050→ 255,050 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-17+121,700→ 437,426 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-15$7.65/sh−21,210→ 315,726 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-12$7.57/sh−8,540→ 336,936 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-03$7.65/sh−19,770→ 345,476 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-02$7.21/sh−50,906→ 365,246 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-01$3.22/sh+91,004→ 507,156 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2025-12-01−91,004→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-01$7.10/sh−91,004→ 416,152 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19+120,700→ 415,190 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19$7.39/sh−2,461→ 412,729 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2024-12-19+250,100→ 250,100 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-14$7.53/sh−8,613→ 294,490 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-13$5.53/sh+5,000→ 300,762 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-19$6.05/sh−2,482→ 293,539 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2023-12-14+158,500→ 158,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14+64,000→ 300,036 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14$6.43/sh−4,015→ 296,021 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-12-19+158,500→ 158,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-19+34,000→ 232,770 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-15$10.88/sh−4,175→ 198,770 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-14+75,000→ 221,969 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-12-14+164,000→ 164,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-14+55,000→ 201,969 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-05-12−35,852→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-12$4.73/sh+35,852→ 146,127 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-11$1.42/sh+33,132→ 145,055 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-11$4.73/sh+1,648→ 111,923 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-11$5.45/sh+68,000→ 213,055 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-05-11−33,132→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-05-11$12.04/sh−102,780→ 110,275 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-05-11−1,648→ 35,852 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-05-11−68,000→ 0 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-15+280,000→ 280,000 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-11−13,741→ 0 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-12-11$7.96/sh−13,741→ 108,061 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-12-11$4.15/sh+13,741→ 121,802 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-12-04$6.23/sh−13,741→ 108,061 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-04−13,741→ 13,741 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2020-12-04$4.15/sh+13,741→ 121,802 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-12-03+17,000→ 17,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-02-21+12,400→ 12,400 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-02-14+21,700→ 21,700 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-12-17+190,000→ 190,000 total

Companies

BIOCRYST PHARMACEUTICALS INC
Chief Legal Officer
$BCRX

Recent Filings

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703

View on SEC.gov